No Intervention: Observational Cohort
OtherNo Intervention: Observational Cohort
NCT Number: NCT06860945
Objective: To develop and validate a predictive model for acquiring sexually transmitted infections (STIs) in individuals using HIV pre-exposure prophylaxis (PrEP) within the national program providing this strategy.
Methods: Ambispective cohort study, multicentric (23 Spanish hospitals). All PrEP users, with follow-up within the program, will be included. Entry into the program will be considered as the baseline visit. From there, patients are followed quarterly, following the national protocols for monitoring PrEP users in Spain. At each visit, diagnosis of different STIs (serum, pharyngeal swab, urethral or urine sample, rectal swab, endocervical/vaginal swab, ulcer) is performed. Primary outcome variable: development of an STI (Yes/No). The following STIs will be considered: syphilis, Neisseria gonorrhoeae (NG) infection, Chlamydia trachomatis (CT) infection, lymphogranuloma venereum (LGV), Mycoplasma genitalium (MG) infection, genital herpes, hepatitis A, hepatitis B, hepatitis C, HIV infection, and MPOX. Secondary outcome variable: number of diagnosed STIs. In order to determine factors associated with acquiring an STI, multivariate analyses will be conducted using logistic regression. The best models will be analyzed in the validation population. To compare the models, we will follow the Bayesian approach suggested by Benavoli et al.
Interested in participating?
Request Info16 year and older
All sexes
Observational
Hospital Universitario de Torrecárdenas, Almería, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The approved criteria for the use of oral PrEP in Spain, as recommended by the Spanish Gesida guidelines (GeSIDA. Recomendaciones sobre la Profilaxis Pre-Exposición para la Prevención de la Infección por VIH en España. Marzo 2023. Available at http://.gesida-seimc.org/category/guias-clinicas/otras-guias-vigentes/), are as follows:
Exclusion criteria
none
-
No Intervention: Observational Cohort
Time frame: through study completion, an average of 5 years
Predictive model for the acquisition of sexually transmitted infections in individuals using PrEP within the national provision program for this strategy
Time frame: through study completion, an average of 5 years
Incidence of sexually transmitted infections (STIs) in the cohort globally and by type of infection.
Time frame: through study completion, an average of 5 years
Evolution of STI diagnoses during follow-up among PrEP users included in the study, both globally and by specific pathogen
Time frame: through study completion, an average of 5 years
Proportion of asymptomatic STIs diagnosed within the screening program.
Time frame: through study completion, an average of 5 years
Sexual risk behaviors of individuals in the cohort, before and after initiating PrEP
Time frame: through study completion, an average of 5 years
Proportion of Individuals who might benefit from the 'Doxy-PEP' strategy (doxycycline use as post-exposure prophylaxis for chlamydia and syphilis)
Time frame: through study completion, an average of 5 years
Prevalence of oral PrEP discontinuation within a nationwide PrEP users' cohort.
Time frame: through study completion, an average of 5 years
Predictors of oral PrEP discontinuation within a nationwide PrEP users' cohort.
Time frame: through study completion, an average of 5 years
Self-reported oral PrEP adherence.
Time frame: through study completion, an average of 5 years
Time elapsed between oral PrEP initiation and oral PrEP discontinuation.
Time frame: through study completion, an average of 5 years
Incidence of HIV seroconversions
Time frame: through study completion, an average of 5 years
Profiles of those who acquire HIV while taking oral PrEP.
Contact information is provided by the study sponsor or research team.
Hospital Universitario de Valme
Other
Acronym: STI_PrEPare
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06919614
Bacterial Infections, Bacterial Infections and Mycoses
Gaborone, Botswana
View Trial DetailsNCT06738407
Bacterial Infections, Bacterial Infections and Mycoses
Los Angeles, California, United States
View Trial DetailsNCT07509853
Behavior, Chemically-Induced Disorders
Pathum Wan, Bangkok, Thailand
View Trial DetailsNCT07512869
Behavior, Chemically-Induced Disorders
Pathum Wan, Bangkok, Thailand
View Trial Details